Engineering the future of aging medicine.

Multimodal aging datasets and AI-driven drug discovery for age-related disease.

What we do

We are an aging science company developing multimodal biological datasets and AI to discover transformative therapeutics for age-related diseases.

We are advancing a portfolio of small molecule therapeutics targeting age-related pathways.

Applying insights from aging biology, our pipeline focuses on cardiometabolic disease from new angles.

01.

Aging datasets

We generate differentiated datasets across cellular and whole-organism models.

02.

Drug design

We apply our novel chemistry tools to design and optimize small molecules.

03.

We leverage AI to augment our dual biology and chemistry platforms.

Engineering the future of aging medicine –

Newsroom